![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5717041/bin/41598_2017_17175_Fig2_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC
![The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology](https://cdn.amegroups.cn/journals/tgh/files/journals/26/articles/4987/public/4987-PB4-8827-R1.png/w300)
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41598-020-80778-0/MediaObjects/41598_2020_80778_Fig1_HTML.png)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma](https://www.jcancer.org/v09/p3117/jcav09p3117g005.jpg)
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig3_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology](https://cdn.amegroups.cn/journals/tgh/files/journals/26/articles/4987/public/4987-PB3-3258-R1.png/w300)
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
![Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma](https://www.jcancer.org/v09/p3117/jcav09p3117g007.jpg)
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma](https://www.jcancer.org/v09/p3117/jcav09p3117g003.jpg)
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig2_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41390-021-01666-5/MediaObjects/41390_2021_1666_Fig1_HTML.png)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma](https://www.jcancer.org/v09/p3117/jcav09p3117g004.jpg)
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000989811830069X-gr1.jpg)
The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1038%2Fs41598-021-82177-5/MediaObjects/41598_2021_82177_Fig1_HTML.png)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-020-03200-2/MediaObjects/432_2020_3200_Fig2_HTML.png)
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356519312388-gr1.jpg)